Year: 2025
Type: article
Abstract: 压力性尿失禁(stress urinary incontinence, SUI)是一个影响女性身心健康的难题，近年来，随着我国人口政策的调整、社会老龄化的发展，其发病率也逐年上升。压力性尿失禁不仅严重降低了患者的生活质量，还增加了患者焦虑、抑郁等精神心理负担。现有疗法只能缓解患者症状，无法彻底治愈。干细胞是一类具有多向分化、自我更新能力的细胞，随着细胞生物学和组织工程技术的发展，其潜在的临床治疗作用引起了人们的关注。本文总结了近年来干细胞在治疗压力性尿失禁中的研究进展，并对其局限性和未来应用进行了讨论和展望。Stress urinary incontinence is a challenging issue affecting women’s physical and mental health. In recent years, with adjustments in population policies and the development of social aging in China, its incidence has been increasing annually. Stress urinary incontinence not only severely reduces patients’ quality of life but also increases their psychological burdens such as anxiety and depression. Current therapies can only alleviate symptoms without providing a complete cure. Stem cells are a type of cell with multi-directional differentiation and self-renewal capabilities. With advancements in cell biology and tissue engineering technology, their potential clinical therapeutic effects have garnered attention. This paper summarizes recent research progress on the use of stem cells in treating stress urinary incontinence, discusses their limitations, and explores future applications.
Source: Advances in Clinical Medicine
Author: 凡政 孔
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4410244864